@article{4e6879d8bb5d4ced9288130f0b96945b,
title = "Translocations disrupting PHF21A in the Potocki-Shaffer-syndrome region are associated with intellectual disability and craniofacial anomalies",
abstract = "Potocki-Shaffer syndrome (PSS) is a contiguous gene disorder due to the interstitial deletion of band p11.2 of chromosome 11 and is characterized by multiple exostoses, parietal foramina, intellectual disability (ID), and craniofacial anomalies (CFAs). Despite the identification of individual genes responsible for multiple exostoses and parietal foramina in PSS, the identity of the gene(s) associated with the ID and CFA phenotypes has remained elusive. Through characterization of independent subjects with balanced translocations and supportive comparative deletion mapping of PSS subjects, we have uncovered evidence that the ID and CFA phenotypes are both caused by haploinsufficiency of a single gene, PHF21A, at 11p11.2. PHF21A encodes a plant homeodomain finger protein whose murine and zebrafish orthologs are both expressed in a manner consistent with a function in neurofacial and craniofacial development, and suppression of the latter led to both craniofacial abnormalities and neuronal apoptosis. Along with lysine-specific demethylase 1 (LSD1), PHF21A, also known as BHC80, is a component of the BRAF-histone deacetylase complex that represses target-gene transcription. In lymphoblastoid cell lines from two translocation subjects in whom PHF21A was directly disrupted by the respective breakpoints, we observed derepression of the neuronal gene SCN3A and reduced LSD1 occupancy at the SCN3A promoter, supporting a direct functional consequence of PHF21A haploinsufficiency on transcriptional regulation. Our finding that disruption of PHF21A by translocations in the PSS region is associated with ID adds to the growing list of ID-associated genes that emphasize the critical role of transcriptional regulation and chromatin remodeling in normal brain development and cognitive function.",
author = "Kim, {Hyung Goo} and Kim, {Hyun Taek} and Leach, {Natalia T.} and Fei Lan and Reinhard Ullmann and Asli Silahtaroglu and Ingo Kurth and Anja Nowka and Seong, {Ihn Sik} and Yiping Shen and Talkowski, {Michael E.} and Douglas Ruderfer and Lee, {Ji Hyun} and Caron Glotzbach and Kyungsoo Ha and Susanne Kjaergaard and Levin, {Alex V.} and Romeike, {Bernd F.} and Tjitske Kleefstra and Oliver Bartsch and Elsea, {Sarah H.} and Jabs, {Ethylin Wang} and MacDonald, {Marcy E.} and Harris, {David J.} and Quade, {Bradley J.} and Ropers, {Hans Hilger} and Shaffer, {Lisa G.} and Kerstin Kutsche and Layman, {Lawrence C} and Niels Tommerup and Kalscheuer, {Vera M.} and Yang Shi and Morton, {Cynthia C.} and Kim, {Cheol Hee} and Gusella, {James F.}",
note = "Funding Information: We are grateful to DGAP012 and MCN1762, as well as their family members, for their cooperation and participation in this study. We are also indebted to Amy Bosco, Heather L. Ferguson, and Chantal Kelly for obtaining informed consent and clinical information; to Joanne Sutherland, genetic counselor at the Hospital for Sick Children, Toronto, for her assistance in obtaining samples; to Shigeki Iwase and Tadashi Baba for the PHF21A antibody; to Mary Anne Anderson and Tammy Gillis in the Center for Human Genetic Research Tissue Culture Facility and Genomics Resource for technical assistance; to Ian Krantz, Stephanie Seminara, and Simeon A. Boyadjiev for providing samples of affected individuals; and to Ines M{\"u}ller and Corinna Menzel for technical assistance. This work was supported by a grant from the Next-Generation BioGreen 21 Program (PJ00812701 to C.H.K.), Republic of Korea, a grant from the Deutsche Forschungsgemeinschaft (KU 1240/5-1 to K.K.), the Danish National Research Foundation (N.T.), the Lundbeck Foundation (N.T. and A.S.), National Institutes of Health grants NCI118487 (to Y.S.) and RO1 GM071004 (to Y.S.), and United States Public Health Service grants GM061354 (Developmental Genome Anatomy Project to C.C.M. and J.F.G.) and HD065286 (to J.F.G.). Part of this work was financed by the European Union's Seventh Framework Program under grant agreement number 241995, project GENCODYS, and the German Federal Ministry of Education and Research through the German Mental Retardation Network (grant 01GS08161 to H.H.R.). ",
year = "2012",
month = jul,
day = "13",
doi = "10.1016/j.ajhg.2012.05.005",
language = "English (US)",
volume = "91",
pages = "56--72",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "1",
}